LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Acquisition Potential Pardes Biosciences has recently been acquired by Medi Corp and Midpac. This change in ownership could present an opportunity for sales representatives to introduce new products or services to the acquiring companies.

C-level Transition Phil Tinmouth, the former Chief Business and Strategy Officer, has left Pardes Biosciences. This leadership change may create openings for sales professionals to engage with the company's new executives to explore potential collaborations or partnerships.

Leadership Change Thomas G. Wiggans was appointed as CEO and Chairman of Pardes. Sales development representatives can leverage this change in leadership to establish new relationships with key decision-makers and showcase solutions that align with the company's vision under the new leadership.

Product Development Focus Pardes Biosciences is actively developing PBI-0451, a potential oral antiviral drug candidate for COVID-19 treatment and prevention. Sales teams can tailor their pitches to showcase how their offerings complement or support Pardes' product development efforts in this critical area.

Financial Positioning With $75 million in funding, Pardes has the financial backing to invest in new technologies and partnerships. Sales professionals can position their solutions as value-driven investments that can help Pardes achieve its strategic goals and maximize return on investment.

Similar companies to Pardes Biosciences

✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Pardes Biosciences Tech Stack

Pardes Biosciences uses 8 technology products and services including QuickBooks, WordPress, Font Awesome, and more. Explore Pardes Biosciences's tech stack below.

  • QuickBooks
    Accounting And Finance
  • WordPress
    Content Management System
  • Font Awesome
    Font Scripts
  • RSS
    Miscellaneous
  • Acquia Cloud Platform
    Platform As A Service
  • BambooHR
    Recruitment Marketing
  • Akamai Bot Manager
    Security
  • OpenResty
    Web Servers

Media & News

Pardes Biosciences's Email Address Formats

Pardes Biosciences uses at least 1 format(s):
Pardes Biosciences Email FormatsExamplePercentage
First.Last@pardesbio.comJohn.Doe@pardesbio.com
51%
First@pardesbio.comJohn@pardesbio.com
30%
FLast@pardesbio.comJDoe@pardesbio.com
15%
FirstLast@pardesbio.comJohnDoe@pardesbio.com
4%

Frequently Asked Questions

Where is Pardes Biosciences's headquarters located?

Minus sign iconPlus sign iconPardes Biosciences's main headquarters is located at Carlsbad, CA US. The company has employees across 1 continents, including North America.

What is Pardes Biosciences's stock symbol?

Minus sign iconPlus sign iconPardes Biosciences is a publicly traded company; the company's stock symbol is PRDS.

What is Pardes Biosciences's official website and social media links?

Minus sign iconPlus sign iconPardes Biosciences's official website is pardesbio.com and has social profiles on LinkedIn.

What is Pardes Biosciences's SIC code NAICS code?

Minus sign iconPlus sign iconPardes Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Pardes Biosciences have currently?

Minus sign iconPlus sign iconAs of July 2023, Pardes Biosciences has approximately 51 employees across 1 continents, including North America. Key team members include Chief Executive Officer: D. A.Chief Business Officer: S. B.Vice President Of Government Affairs: J. M.. Explore Pardes Biosciences's employee directory with LeadIQ.

What industry does Pardes Biosciences belong to?

Minus sign iconPlus sign iconPardes Biosciences operates in the Biotechnology Research industry.

What technology does Pardes Biosciences use?

Minus sign iconPlus sign iconPardes Biosciences's tech stack includes QuickBooksWordPressFont AwesomeRSSAcquia Cloud PlatformBambooHRAkamai Bot ManagerOpenResty.

What is Pardes Biosciences's email format?

Minus sign iconPlus sign iconPardes Biosciences's email format typically follows the pattern of . Find more Pardes Biosciences email formats with LeadIQ.

How much funding has Pardes Biosciences raised to date?

Minus sign iconPlus sign icon As of July 2023, Pardes Biosciences has raised $75M in funding. The last funding round occurred on Dec 27, 2021 for $75M.

When was Pardes Biosciences founded?

Minus sign iconPlus sign iconPardes Biosciences was founded in 2020.
Pardes Biosciences

Pardes Biosciences

Biotechnology ResearchCalifornia, United States51-200 Employees

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to help solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to discover and develop novel oral drug candidates while reimagining the patient journey to access these medicines. By capitalizing on emerging patient-friendly innovations from telehealth to new at-home diagnostic tools, Pardes is cultivating and harvesting the fruits of systemic change. We are on a mission to stop a pandemic and start a movement so patients everywhere can get well sooner.

✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Carlsbad, CA US
Website
pardesbio.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRDS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    Pardes Biosciences has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Dec 27, 2021 in the amount of $75M.

Section iconFunding & Financials

  • $75M

    Pardes Biosciences has raised a total of $75M of funding over 2 rounds. Their latest funding round was raised on Dec 27, 2021 in the amount of $75M.

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Pardes Biosciences and Millions of Other Companies

Sign up for full access to Pardes Biosciences information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.